Longview Ventures
Investor profile
Venture capital
Longview Ventures has backed 2 European tech companies across 2 funding rounds between 2024 and 2025, joining rounds totalling €138M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
2
distinct rounds
Companies
2
backed
Active span
2024–2025
2 yrs
Total round €
€138M
sum of rounds joined
Deals by year
distinct rounds / yearLongview Ventures — deals by year — interactive chart.
Data table
| Longview Ventures — deals by year | |
|---|---|
| 2024 | 1 |
| 2025 | 1 |
Top sectors
by dealsLongview Ventures — top sectors — interactive chart.
Data table
| Longview Ventures — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsLongview Ventures — stages — interactive chart.
Data table
| Longview Ventures — stages | |
|---|---|
| Series A | 2 |
Countries
by dealsLongview Ventures — countries — interactive chart.
Data table
| Longview Ventures — countries | |
|---|---|
| Denmark | 1 |
| Switzerland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- +ND Capital1
- 4see Ventures1
- Alexandria Venture Investments1
- Apollo Health Ventures1
- Athos Capital1
- Bernina BioInvest1
- Dawn Biopharma1
- Earlybird Venture Capital1
- Eli lilly and company1
- Export and Investment Fund of Denmark (EIFO)1
- LifeLink Ventures1
- Novo Holdings1
- Pictet1
- Schroders Capital1
- Sofinnova Partners1
- SR One1
- Versant Ventures1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Antag Therapeutics | Denmark | 1 | €80M |
| haya therapeutics | Switzerland | 1 | €58M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Antag Therapeutics | Series A | €80M | 2024-12 |
| haya therapeutics | Series A | €58M | 2025-05 |